Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
N4-ISOBUTYRYLOXYCYTIDINE ANALOG SYNTHESIS AND COMPOSITION FOR TREATING VIRAL INFECTION COMPRISING ANTI-VIRAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/167382
Kind Code:
A1
Abstract:
The present invention relates to N 4-isobutyryloxycytidine analog synthesis and to the anti-viral use thereof against dengue virus, influenza virus, and SARS-CoV-2 virus.

Inventors:
CHO JONG HYUN (KR)
AN YEON JIN (KR)
CHOI SEMYEONG (KR)
CHOI EUN RANG (KR)
NAM YE EUN (KR)
SEO EUN WOO (KR)
Application Number:
PCT/KR2022/013638
Publication Date:
September 07, 2023
Filing Date:
September 13, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV DONG A RES FOUND FOR IND ACAD COOP (KR)
International Classes:
C07H19/067; A61K31/7068; A61P31/14; A61P31/16
Foreign References:
KR20170123308A2017-11-07
CN111548384A2020-08-18
Other References:
PAYMODE DINESH J., VASUDEVAN N., AHMAD SAEED, KADAM APPASAHEB L., CARDOSO FLAVIO S.P., BURNS JUSTINA M., COOK DANIEL W., STRINGHAM: "Toward a Practical, Two-Step Process for Molnupiravir: Direct Hydroxamination of Cytidine Followed by Selective Esterification", ORGANIC PROCESS RESEARCH & DEVELOPMENT, AMERICAN CHEMICAL SOCIETY, US, vol. 25, no. 8, 20 August 2021 (2021-08-20), US , pages 1822 - 1830, XP093038654, ISSN: 1083-6160, DOI: 10.1021/acs.oprd.1c00033
IVANOV MAKSIM A., ANTONOVA ELENA V., MAKSIMOV ALEKSEY V., PIGUSOVA LYUDMILA K., BELANOV EVGENII F., ALEKSANDROVA LYUDMILA A.: "New N4-Hydroxycytidine Derivatives: Synthesis and Antiviral Activity", COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, vol. 71, no. 7, 1 January 2006 (2006-01-01), pages 1099 - 1106, XP093066626, ISSN: 0010-0765, DOI: 10.1135/cccc20061099
YEON JIN AN: "MEDI.P-554 Synthesis and evaluation of β-D-N4-hydroxycytidine (NHC) prodrugs against SARS-Cov-2 in vitro", 128TH GENERAL MEETING OF THE KOREAN CHEMICAL SOCIETY; 13-15 OCTOBER 2021, KOREAN CHEMICAL SOCIETY, KOREA, 1 January 2021 (2021-01-01) - 15 October 2021 (2021-10-15), Korea, XP009551559
AN, Y. K. et al. Modification and evaluation of β-D-N4-hydroxycytidine (NHC) prodrugs against SARS-Cov-2. 2021, 제24회 한국유기합성학회 학술대회 및 정기 총회 (2021 the 24th Korean Society of Organic Synthesis Conference and Annual Meeting.)
Attorney, Agent or Firm:
WIE, Byoung-Gap (KR)
Download PDF: